|
US7641780B2
(en)
*
|
2001-05-01 |
2010-01-05 |
Calibrant Biosystems, Inc. |
Two-dimensional microfluidics for protein separations and gene analysis
|
|
PL1601450T3
(pl)
|
2003-03-10 |
2014-03-31 |
Expression Pathology Inc |
Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej
|
|
US7294367B2
(en)
*
|
2003-06-06 |
2007-11-13 |
The United States Of America As Represented By The Secretary Of The Navy |
Biological laser printing via indirect photon-biomaterial interactions
|
|
US8012693B2
(en)
|
2003-12-16 |
2011-09-06 |
3M Innovative Properties Company |
Analysis of chemically crosslinked cellular samples
|
|
DE102005023011A1
(de)
*
|
2005-05-19 |
2006-11-23 |
Qiagen Gmbh |
Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
|
|
JP5166250B2
(ja)
*
|
2005-05-25 |
2013-03-21 |
エクスプレッション、パソロジー、インコーポレイテッド |
組織病理学的に処理した生物学的試料からのプロテオームの適用範囲を増加させるための、液体組織標品を用いたマルチプレックス方法
|
|
EP1907845A4
(en)
*
|
2005-05-25 |
2009-03-04 |
Expression Pathology Inc |
DIAGNOSIS OF ILLNESSES AND SUFFERING BY ANALYSIS OF HISTOPATHOLOGICALLY PREPARED BIOLOGICAL SAMPLES USING LIQUID TISSUE PREPARATIONS
|
|
EP1910389A4
(en)
*
|
2005-05-31 |
2010-03-10 |
Life Technologies Corp |
SEPARATION AND PURIFICATION OF NUCLEIC ACID FROM PARAFFIN-SAMPLE SAMPLES
|
|
DE102005027172A1
(de)
|
2005-06-13 |
2006-12-14 |
Merck Patent Gmbh |
Verwendung von Ionischen Flüssigkeiten zur Proteinextraktion
|
|
US20110177492A1
(en)
*
|
2005-06-16 |
2011-07-21 |
3M Innovative Properties Company |
Method of classifying chemically crosslinked cellular samples using mass spectra
|
|
DE102005060738A1
(de)
*
|
2005-12-16 |
2007-06-21 |
Qiagen Gmbh |
Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben
|
|
WO2007112350A2
(en)
*
|
2006-03-24 |
2007-10-04 |
Expression Pathology |
Method of assessing the metastatic status of a primary tumor
|
|
JP2008043332A
(ja)
*
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
|
KR101065571B1
(ko)
*
|
2006-09-28 |
2011-09-19 |
가부시키가이샤 시마즈세이사쿠쇼 |
파라핀 포매 표본의 탈파라핀법 및 파라핀 포매 표본의 해석법
|
|
US20080156080A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
|
|
US20080160629A1
(en)
*
|
2007-01-02 |
2008-07-03 |
Calibrant Biosystems, Inc. |
Methods and systems for off-line multidimensional concentration and separation of biomolecules
|
|
EP2187988B1
(en)
|
2007-07-19 |
2013-08-21 |
Boston Scientific Limited |
Endoprosthesis having a non-fouling surface
|
|
EP2185103B1
(en)
|
2007-08-03 |
2014-02-12 |
Boston Scientific Scimed, Inc. |
Coating for medical device having increased surface area
|
|
US8920491B2
(en)
|
2008-04-22 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical devices having a coating of inorganic material
|
|
US8932346B2
(en)
|
2008-04-24 |
2015-01-13 |
Boston Scientific Scimed, Inc. |
Medical devices having inorganic particle layers
|
|
EP2193831A1
(de)
*
|
2008-12-05 |
2010-06-09 |
Qiagen GmbH |
Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe
|
|
DE102009031434B4
(de)
*
|
2009-07-01 |
2015-03-05 |
Axagarius Gmbh & Co. Kg |
Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit hierfür
|
|
ES2555147T3
(es)
*
|
2009-12-22 |
2015-12-29 |
Expression Pathology, Inc. |
Ensayo SRM/MRM de la proteína del Receptor del factor de crecimiento 1 similar a la insulina (IGF-1R)
|
|
AU2010341482A1
(en)
*
|
2009-12-22 |
2012-07-19 |
Expression Pathology, Inc. |
Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
|
|
EP3267194B1
(en)
|
2009-12-22 |
2019-06-05 |
Expression Pathology, Inc. |
Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay
|
|
JP5873804B2
(ja)
*
|
2009-12-22 |
2016-03-01 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
上皮成長因子受容体(egfr)タンパク質srm/mrmアッセイ
|
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
|
EP2577291A4
(en)
*
|
2010-05-26 |
2014-11-26 |
Expression Pathology Inc |
SELECTIVE REACTION MONITORING OF TYPE-1 PROTEIN INHIBITOR OF PLASMINOGEN ACTIVATOR / UROKINASE PLASMINOGEN ACTIVATORY PROTEIN
|
|
EP2601519B1
(en)
*
|
2010-07-30 |
2017-12-06 |
Expression Pathology, Inc. |
C-src selected reaction monitoring assay
|
|
WO2012048335A2
(en)
|
2010-10-08 |
2012-04-12 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
|
ES2750326T3
(es)
|
2010-12-27 |
2020-03-25 |
Expression Pathology Inc |
Ensayo SRM/MRM de proteína c-MET
|
|
JP6046053B2
(ja)
|
2011-01-13 |
2016-12-14 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
Bcl−2様タンパク質11のSRM/MRMアッセイ
|
|
CN102146112B
(zh)
*
|
2011-01-25 |
2013-07-10 |
天根生化科技(北京)有限公司 |
从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法
|
|
US9372196B2
(en)
|
2011-03-08 |
2016-06-21 |
Bioproximity, Llc |
Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
|
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
|
EP2758779B1
(en)
|
2011-09-22 |
2017-09-06 |
Expression Pathology, Inc. |
Mrm/srm assay for death receptor 5 protein
|
|
CA3045682A1
(en)
|
2011-09-22 |
2013-03-28 |
Expression Pathology, Inc. |
Multiplex mrm assay for evaluation of cancer
|
|
CA2850667A1
(en)
|
2011-10-04 |
2013-04-11 |
Expression Pathology, Inc. |
Srm/mrm assay for the receptor tyrosine-protein kinase erbb-4 protein (her4)
|
|
WO2013083260A1
(en)
*
|
2011-12-06 |
2013-06-13 |
Qiagen Gmbh |
Recovery of a biomolecule comprising aqueous phase from a multiphasic mixture
|
|
WO2013106603A1
(en)
*
|
2012-01-10 |
2013-07-18 |
Expression Pathology, Inc. |
Srm/mrm assay for the insulin receptor protein
|
|
CN103207107B
(zh)
*
|
2012-01-16 |
2016-09-07 |
中国医学科学院北京协和医院 |
硝酸纤维素膜富集体液蛋白质组蛋白的用途
|
|
JP6441215B2
(ja)
|
2012-05-16 |
2018-12-19 |
エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. |
肺組織像を細分類するためのsrm/mrm分析
|
|
US9982290B2
(en)
*
|
2012-10-04 |
2018-05-29 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
|
EP3901280B1
(en)
|
2012-10-17 |
2025-03-12 |
10x Genomics Sweden AB |
Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
|
|
EP2730653A1
(en)
|
2012-11-07 |
2014-05-14 |
QIAGEN GmbH |
Method for lysing a fixed biological sample
|
|
EP3470845B1
(en)
|
2013-03-15 |
2020-05-13 |
Expression Pathology, Inc. |
Srm assay to indicate cancer therapy
|
|
CN105473744B
(zh)
|
2013-06-25 |
2020-06-19 |
普罗格诺西斯生物科学公司 |
采用微流控装置的空间编码生物分析
|
|
WO2015103645A2
(en)
|
2014-01-06 |
2015-07-09 |
Expression Pathology, Inc. |
Srm assay for pd-l1
|
|
KR20160149258A
(ko)
*
|
2014-04-30 |
2016-12-27 |
익스프레션 패톨로지, 인크. |
안드로겐 수용체(ar) 단백질에 대한 srm/mrm 검정
|
|
EP3137631B1
(en)
|
2014-04-30 |
2020-01-15 |
Expression Pathology, Inc. |
Srm/mrm assay for the tyrosine-protein kinase receptor ufo (axl) protein
|
|
AU2015284050A1
(en)
|
2014-07-01 |
2017-02-02 |
Expression Pathology, Inc. |
SRM assays to chemotherapy targets
|
|
CA2954692A1
(en)
*
|
2014-07-11 |
2016-01-14 |
Expression Pathology, Inc. |
Srm/mrm assay for the gtpase kras protein (kras)
|
|
US20190099475A1
(en)
|
2015-04-08 |
2019-04-04 |
Nantomics, Llc |
Cancer neoepitopes
|
|
FI3901281T3
(fi)
|
2015-04-10 |
2023-01-31 |
|
Biologisten näytteiden spatiaalisesti eroteltu moninkertainen nukleiinihappoanalyysi
|
|
CA3172682A1
(en)
|
2015-04-23 |
2016-10-27 |
Nantomics, Llc |
Cancer neoepitopes
|
|
CN107923916A
(zh)
|
2015-05-14 |
2018-04-17 |
爱科谱迅病理研究公司 |
成纤维细胞生长因子受体2(fgfr2)蛋白质的srm/mrm测定
|
|
WO2016183595A1
(en)
|
2015-05-14 |
2016-11-17 |
Expression Pathology, Inc. |
Srm/mrm assay for the 6-o-methylguanine-dna methyltransferase (mgmt) protein
|
|
JP6605623B2
(ja)
*
|
2015-05-14 |
2019-11-13 |
エクスプレッション、パソロジー、インコーポレイテッド |
メソテリン(msln)タンパク質のためのsrm/mrmアッセイ
|
|
CA2986730C
(en)
|
2015-05-22 |
2020-04-14 |
Expression Pathology, Inc. |
Srm/mrm assay for the cyclin-dependent kinase inhibitor 2a (p16) protein
|
|
KR102067327B1
(ko)
|
2015-05-29 |
2020-02-11 |
익스프레션 패톨로지, 인크. |
최적의 암 치료를 위한 Her2 단백질 정량
|
|
CN108135902A
(zh)
|
2015-07-30 |
2018-06-08 |
爱科谱迅病理研究公司 |
用于最优癌症治疗的定量FR-α和GART蛋白质
|
|
AU2016325715B2
(en)
|
2015-09-24 |
2019-04-04 |
Expression Pathology, Inc. |
Quantifying Met protein for cancer treatment
|
|
EP3362103B1
(en)
|
2015-10-12 |
2025-01-22 |
Nantomics, LLC |
Compositions and methods for viral cancer neoepitopes
|
|
JP2018532736A
(ja)
|
2015-10-12 |
2018-11-08 |
ナントミクス,エルエルシー |
チェックポイント阻害物質への感受性を予測するmsiおよびネオエピトープの探索のための系、組成物、および方法
|
|
CN108604257B
(zh)
|
2015-10-12 |
2022-12-13 |
南托米克斯有限责任公司 |
产生特异性免疫治疗组合物及其相关核酸构建体的方法
|
|
EP3855444B1
(en)
|
2015-10-12 |
2024-09-04 |
Nantomics, LLC |
Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
|
|
TWI733719B
(zh)
|
2015-12-07 |
2021-07-21 |
美商河谷控股Ip有限責任公司 |
改善的組合物及用於新表位之病毒遞送的方法及其應用
|
|
TW201739919A
(zh)
|
2016-02-12 |
2017-11-16 |
南坦生物組學有限責任公司 |
患者特異性新抗原決定基之高通量識別以作為用於癌症免疫療法之治療劑
|
|
DK3222719T3
(da)
*
|
2016-03-24 |
2020-05-11 |
Allflex Europe Sa |
Anvendelse af en vandig sammensætning til opløsning af biomolekyler fra en vævsprøve
|
|
EP3475434A4
(en)
|
2016-03-24 |
2020-07-29 |
Nantcell, Inc. |
SEQUENCES AND SEQUENCES ARRANGEMENTS FOR PRESENTATION OF NEO-EPITOPIA
|
|
US20180172690A1
(en)
*
|
2016-04-20 |
2018-06-21 |
Expression Pathology, Inc. |
Method for improved hepatocellular cancer diagnosis
|
|
US20190292259A1
(en)
|
2016-05-24 |
2019-09-26 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
|
WO2018039567A1
(en)
|
2016-08-25 |
2018-03-01 |
Nantomics, Llc |
Immunotherapy markers and uses therefor
|
|
WO2018089637A1
(en)
|
2016-11-11 |
2018-05-17 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
|
WO2018102613A2
(en)
|
2016-12-01 |
2018-06-07 |
Nantomics, Llc |
Tumor antigenicity processing and presentation
|
|
US10617717B2
(en)
|
2016-12-04 |
2020-04-14 |
Expression Pathology, Inc. |
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
|
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
|
AU2018226852A1
(en)
*
|
2017-03-03 |
2019-10-17 |
Expression Pathology, Inc. |
Immune profiling of tumor tissue
|
|
CA3061240C
(en)
|
2017-04-24 |
2024-01-16 |
Nantcell, Inc. |
Targeted neoepitope vectors and methods therefor
|
|
EP3619534A1
(en)
|
2017-05-05 |
2020-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
|
|
EP3631471A4
(en)
|
2017-05-30 |
2021-06-30 |
Nant Holdings IP, LLC |
Circulating tumor cell enrichment using neoepitopes
|
|
EP3688165A4
(en)
|
2017-09-25 |
2021-09-29 |
Nant Holdings IP, LLC |
VALIDATION OF THE PRESENTATION OF NEOEPITOPES
|
|
US10722509B2
(en)
*
|
2018-01-16 |
2020-07-28 |
Nantomics, Llc |
Predicting optimal chemotherapy for CRC
|
|
US10722531B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
OPRT expression and cancer treatment outcome
|
|
US10725045B2
(en)
|
2018-02-13 |
2020-07-28 |
Nantomics, Llc |
Quantifying MGMT protein for optimal cancer therapy of glioblastoma
|
|
AU2019201463A1
(en)
|
2018-03-09 |
2019-09-26 |
Nantomics, Llc |
Srm/mrm assays for profiling tumor tissue
|
|
US20190353660A1
(en)
|
2018-05-17 |
2019-11-21 |
Nantomics, Llc |
Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)
|
|
US11519033B2
(en)
|
2018-08-28 |
2022-12-06 |
10X Genomics, Inc. |
Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
|
|
WO2020077128A1
(en)
|
2018-10-11 |
2020-04-16 |
Nantomics, Llc |
Tumor hla mutation versus matched normal hla
|
|
KR20200050374A
(ko)
|
2018-10-30 |
2020-05-11 |
익스프레션 패톨로지, 인크. |
노치 경로 단백질용 srm/mrm 분석
|
|
EP3894592A2
(en)
|
2018-12-10 |
2021-10-20 |
10X Genomics, Inc. |
Generating spatial arrays with gradients
|
|
US12529094B2
(en)
|
2018-12-10 |
2026-01-20 |
10X Genomics, Inc. |
Imaging system hardware
|
|
US20220073626A1
(en)
|
2019-01-03 |
2022-03-10 |
Institut National De La Santé Et De La Recheche Médicale (Inserm) |
Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in subjects suffering from cancer
|
|
US11926867B2
(en)
|
2019-01-06 |
2024-03-12 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
|
US11649485B2
(en)
|
2019-01-06 |
2023-05-16 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
|
KR20200087700A
(ko)
|
2019-01-11 |
2020-07-21 |
난토믹스, 엘엘씨 |
질량 분석법에 의한 sdhb 단백질 발현의 평가
|
|
WO2020201362A2
(en)
|
2019-04-02 |
2020-10-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
|
WO2020208060A1
(en)
|
2019-04-09 |
2020-10-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
|
|
EP3976820A1
(en)
|
2019-05-30 |
2022-04-06 |
10X Genomics, Inc. |
Methods of detecting spatial heterogeneity of a biological sample
|
|
JP7554779B2
(ja)
|
2019-06-03 |
2024-09-20 |
アンスティチュート、ナシオナル、ドゥ、ラ、サンテ、エ、ドゥ、ラ、ルシェルシュ、メディカル |
処置レジメンを調節する方法
|
|
JP7215467B2
(ja)
*
|
2019-08-19 |
2023-01-31 |
株式会社島津製作所 |
ホルマリン固定パラフィン包埋組織試料からの抗体の分離、検出及び/又は分析方法
|
|
US20240301497A1
(en)
|
2019-10-17 |
2024-09-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
|
EP4045912A1
(en)
|
2019-10-18 |
2022-08-24 |
Reccan Diagnostics AB |
Apparatuses and methods for detection of pancreatic cancer
|
|
EP4025711A2
(en)
|
2019-11-08 |
2022-07-13 |
10X Genomics, Inc. |
Enhancing specificity of analyte binding
|
|
ES2946357T3
(es)
|
2019-12-23 |
2023-07-17 |
10X Genomics Inc |
Métodos para el análisis espacial usando ligación con molde de ARN
|
|
WO2021133842A1
(en)
|
2019-12-23 |
2021-07-01 |
10X Genomics, Inc. |
Compositions and methods for using fixed biological samples in partition-based assays
|
|
CN115135984B
(zh)
|
2019-12-23 |
2025-12-23 |
10X基因组学有限公司 |
可逆固定试剂及其使用方法
|
|
US12365942B2
(en)
|
2020-01-13 |
2025-07-22 |
10X Genomics, Inc. |
Methods of decreasing background on a spatial array
|
|
US12405264B2
(en)
|
2020-01-17 |
2025-09-02 |
10X Genomics, Inc. |
Electrophoretic system and method for analyte capture
|
|
US11702693B2
(en)
|
2020-01-21 |
2023-07-18 |
10X Genomics, Inc. |
Methods for printing cells and generating arrays of barcoded cells
|
|
US11732299B2
(en)
|
2020-01-21 |
2023-08-22 |
10X Genomics, Inc. |
Spatial assays with perturbed cells
|
|
US20210230681A1
(en)
|
2020-01-24 |
2021-07-29 |
10X Genomics, Inc. |
Methods for spatial analysis using proximity ligation
|
|
US12076701B2
(en)
|
2020-01-31 |
2024-09-03 |
10X Genomics, Inc. |
Capturing oligonucleotides in spatial transcriptomics
|
|
US11898205B2
(en)
|
2020-02-03 |
2024-02-13 |
10X Genomics, Inc. |
Increasing capture efficiency of spatial assays
|
|
US12110541B2
(en)
|
2020-02-03 |
2024-10-08 |
10X Genomics, Inc. |
Methods for preparing high-resolution spatial arrays
|
|
US11732300B2
(en)
|
2020-02-05 |
2023-08-22 |
10X Genomics, Inc. |
Increasing efficiency of spatial analysis in a biological sample
|
|
US12129516B2
(en)
|
2020-02-07 |
2024-10-29 |
10X Genomics, Inc. |
Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
|
|
US12281357B1
(en)
|
2020-02-14 |
2025-04-22 |
10X Genomics, Inc. |
In situ spatial barcoding
|
|
US11891654B2
(en)
|
2020-02-24 |
2024-02-06 |
10X Genomics, Inc. |
Methods of making gene expression libraries
|
|
US11926863B1
(en)
|
2020-02-27 |
2024-03-12 |
10X Genomics, Inc. |
Solid state single cell method for analyzing fixed biological cells
|
|
EP4110955A1
(en)
|
2020-02-28 |
2023-01-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
|
CN115335519A
(zh)
*
|
2020-03-31 |
2022-11-11 |
凯杰有限公司 |
从固定的生物样品纯化核酸
|
|
WO2021207610A1
(en)
|
2020-04-10 |
2021-10-14 |
10X Genomics, Inc. |
Cold protease treatment method for preparing biological samples
|
|
CN115916972A
(zh)
|
2020-04-16 |
2023-04-04 |
10X基因组学有限公司 |
用于被固定样品的组合物和方法
|
|
EP4549582A3
(en)
|
2020-04-22 |
2025-06-18 |
10x Genomics, Inc. |
Methods for spatial analysis using targeted rna depletion
|
|
EP4553168A3
(en)
|
2020-05-22 |
2025-08-27 |
10x Genomics, Inc. |
Spatial analysis to detect sequence variants
|
|
ES2989052T3
(es)
|
2020-05-22 |
2024-11-25 |
10X Genomics Inc |
Medición espacio-temporal simultánea de la expresión génica y la actividad celular
|
|
US12031177B1
(en)
|
2020-06-04 |
2024-07-09 |
10X Genomics, Inc. |
Methods of enhancing spatial resolution of transcripts
|
|
WO2021252499A1
(en)
|
2020-06-08 |
2021-12-16 |
10X Genomics, Inc. |
Methods of determining a surgical margin and methods of use thereof
|
|
ES2994976T3
(en)
|
2020-06-25 |
2025-02-05 |
10X Genomics Inc |
Spatial analysis of dna methylation
|
|
US20230235408A1
(en)
|
2020-06-30 |
2023-07-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
|
|
JP7741831B2
(ja)
|
2020-06-30 |
2025-09-18 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
術前補助療法及び根治手術後の固形がんを患っている患者の再発及び/又は死亡のリスクを予測するための方法
|
|
US12209280B1
(en)
|
2020-07-06 |
2025-01-28 |
10X Genomics, Inc. |
Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
|
|
US11981960B1
(en)
|
2020-07-06 |
2024-05-14 |
10X Genomics, Inc. |
Spatial analysis utilizing degradable hydrogels
|
|
US11761038B1
(en)
|
2020-07-06 |
2023-09-19 |
10X Genomics, Inc. |
Methods for identifying a location of an RNA in a biological sample
|
|
EP4189110A1
(en)
|
2020-07-31 |
2023-06-07 |
10X Genomics, Inc. |
De-crosslinking compounds and methods of use for spatial analysis
|
|
US11981958B1
(en)
|
2020-08-20 |
2024-05-14 |
10X Genomics, Inc. |
Methods for spatial analysis using DNA capture
|
|
US11926822B1
(en)
|
2020-09-23 |
2024-03-12 |
10X Genomics, Inc. |
Three-dimensional spatial analysis
|
|
WO2022103712A1
(en)
|
2020-11-13 |
2022-05-19 |
10X Genomics, Inc. |
Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays
|
|
US11827935B1
(en)
|
2020-11-19 |
2023-11-28 |
10X Genomics, Inc. |
Methods for spatial analysis using rolling circle amplification and detection probes
|
|
EP4121555B1
(en)
|
2020-12-21 |
2026-02-25 |
10X Genomics, Inc. |
Methods for capturing probes and/or barcodes
|
|
KR20240012352A
(ko)
|
2021-03-23 |
2024-01-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
T 세포 림프종의 진단 및 치료 방법
|
|
WO2022221425A1
(en)
|
2021-04-14 |
2022-10-20 |
10X Genomics, Inc. |
Methods of measuring mislocalization of an analyte
|
|
EP4320271B1
(en)
|
2021-05-06 |
2025-03-19 |
10X Genomics, Inc. |
Methods for increasing resolution of spatial analysis
|
|
EP4347879B1
(en)
|
2021-06-03 |
2025-02-19 |
10X Genomics, Inc. |
Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
|
|
WO2023034489A1
(en)
|
2021-09-01 |
2023-03-09 |
10X Genomics, Inc. |
Methods, compositions, and kits for blocking a capture probe on a spatial array
|
|
EP4419707A1
(en)
|
2021-11-10 |
2024-08-28 |
10X Genomics, Inc. |
Methods, compositions, and kits for determining the location of an analyte in a biological sample
|
|
WO2023102118A2
(en)
|
2021-12-01 |
2023-06-08 |
10X Genomics, Inc. |
Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
|
|
WO2023121449A1
(en)
|
2021-12-21 |
2023-06-29 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Central nervous system organoids
|
|
EP4472740A1
(en)
|
2022-01-31 |
2024-12-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
|
AU2022447608A1
(en)
|
2022-03-17 |
2024-09-26 |
Assistance Publique - Hôpitaux De Paris |
Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
|
|
EP4508432A1
(en)
|
2022-04-11 |
2025-02-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t-cell malignancies
|
|
WO2023198874A1
(en)
|
2022-04-15 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t cell-lymphomas
|
|
JP2023167619A
(ja)
*
|
2022-05-12 |
2023-11-24 |
株式会社日立製作所 |
タンパク質の分析方法
|
|
WO2023245190A1
(en)
|
2022-06-17 |
2023-12-21 |
10X Genomics, Inc. |
Catalytic de-crosslinking of samples for in situ analysis
|
|
WO2024003310A1
(en)
|
2022-06-30 |
2024-01-04 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of acute lymphoblastic leukemia
|
|
EP4558823A1
(en)
|
2022-07-22 |
2025-05-28 |
Institut National de la Santé et de la Recherche Médicale |
Garp as a biomarker and biotarget in t-cell malignancies
|
|
WO2024023283A1
(en)
|
2022-07-29 |
2024-02-01 |
Institut National de la Santé et de la Recherche Médicale |
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
|
|
EP4602372A1
(en)
|
2022-10-12 |
2025-08-20 |
Institut National de la Santé et de la Recherche Médicale |
Cd81 as a biomarker and biotarget in t-cell malignancies
|
|
EP4482979B1
(en)
|
2022-11-09 |
2025-10-01 |
10X Genomics, Inc. |
Methods, compositions, and kits for determining the location of multiple analytes in a biological sample
|